Associate Professor in Hepatology at the University of Nottingham and an Honorary Consultant Hepatologist at the Nottingham University Hospitals NHS Trust, UK.
United Kingdom
Prof. Aloysious Dominic Aravinthan is an Associate Professor in Hepatology at the University of Nottingham and an Honorary Consultant Hepatologist at the Nottingham University Hospitals NHS Trust, UK. He was awarded the prestigious Sheila Sherlock Research Award by the British Association for the Study of the Liver in 2014 and the Sheila Sherlock Travelling Fellowship by the Royal College of Physicians in 2015.
Prof. Aloysious Dominic Aravinthan is an Associate Professor in Hepatology at the University of Nottingham and an Honorary Consultant Hepatologist at Nottingham University Hospitals NHS Trust, UK. He also practises as a Consultant Hepatologist at The Park Hospital in Nottingham. His clinical expertise encompasses the assessment and management of liver diseases, including chronic liver disease, cirrhosis, liver failure and hepatocellular carcinoma.
Prof. Aravinthan completed his specialist postgraduate training in gastroenterology and hepatology within the East of England, including advanced training at Cambridge University Hospitals NHS Foundation Trust. He subsequently undertook a fellowship in transplant hepatology at Toronto General Hospital and the University of Toronto in Canada. He was awarded a PhD by the University of Cambridge for research examining hepatocyte senescence and its role in the progression of chronic liver disease.
His academic work combines clinical, translational and laboratory-based research. His principal research interests include cellular senescence in chronic liver disease, liver fibrosis, novel prognostic and therapeutic biomarkers, rare liver disorders, liver transplantation outcomes and liver cancer. His published work has examined hepatocellular carcinoma surveillance and early detection, the biology of hepatocyte senescence and the clinical epidemiology of chronic and rare liver diseases.
Prof. Aravinthan has contributed to national initiatives aimed at improving the quality and consistency of hepatocellular carcinoma surveillance in the United Kingdom, including NHS England standards for patients at risk of developing liver cancer. His academic achievements have been recognised through the Sheila Sherlock Research Award from the British Association for the Study of the Liver in 2014 and the Sheila Sherlock Travelling Fellowship from the Royal College of Physicians in 2015. He is a Fellow of the Royal College of Physicians of London and the Royal College of Physicians and Surgeons of Glasgow.
University of Nottingham & Nottingham University Hospitals NHS Trust, UK
University of Toronto, Toronto, Canada
Health Education East of England, UK
Royal College of Physicians, London, UK
2020
University of Cambridge, UK
2014
Federation of Royal Colleges of Physicians & British Society of Gastroenterology, UK
2014
University of Colombo, Sri Lanka
2003
Membership of the Royal Colleges of Physicians (MRCP) (2007)